← ANALYST RATINGS · TIPRANKS
Evolent Health (EVH): analyst forecast and price target
Analyst consensus
Strong Buy5 Buy1 Hold0 Sell
Ratings of 6 analysts in the last 3 months · top analysts only12-month forecast
Based on 6 price targets given in the last 3 months, the average target is $5.20, the highest $6.00, the lowest $3.00. The average is +13.8% from the last price of $4.57.
Analyst ratings 15
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Healthcare Information ServicesxAI Grok-3 | TipRanks - xAI | $3.50 → $4.50+28.6% | Hold | −1.5% | Reiterated | 15.10.26on TipRanks 00:06 | — | |
| AI DeepSeek Medical - Healthcare Information ServicesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $3.50 → $4.50+28.6% | Hold | −1.5% | Reiterated | 15.10.26on TipRanks 00:06 | — | |
| AI OpenAI Medical - Healthcare Information ServicesOpenAI 5.2 | TipRanks - OpenAI | $3.50 → $4.50+28.6% | Hold | −1.5% | Reiterated | 15.10.26on TipRanks 00:06 | — | |
| AI Anthropic Medical - Healthcare Information ServicesAnthropic Opus-4.5 | TipRanks - Anthropic | $3.50 → $4.50+28.6% | Sell | −1.5% | Reiterated | 15.10.26on TipRanks 00:06 | — | |
| AI Google Medical - Healthcare Information ServicesGemini 3-pro | TipRanks - Google | $3.50 → $4.50+28.6% | Hold | −1.5% | Reiterated | 15.10.26on TipRanks 00:06 | — | |
| AI PerPlexity Medical - Healthcare Information ServicesPerPlexity SonarPro | TipRanks - PerPlexity | $4.50 → $4.00−11.1% | Hold | −12.5% | Reiterated | 11.10.26on TipRanks 00:05 | — | |
| Ryan Halsted★★★★★★★★★★#3317 · hits 60% · avg +9.0% | RBC Capital | $3.00 | Hold | −34.4% | Reiterated | 06.10.26on TipRanks 21:45 | +8.1%next day −3.9% · 5 days +15.2% | ↗ |
| John Stansel★★★★★★★★★★#9374 · hits 46% · avg −2.3% | J.P. Morgan | $5.00 → $6.00+20.0% | Buy | +31.3% | Assigned | 18.08.26on TipRanks 07:20 | +4.5%next day −0.2% · 5 days +7.0% | ↗ |
| Charles Rhyee★★★★★★★★★★#1937 · hits 54% · avg +5.6% | TD Cowen | $5.00 → $6.00+20.0% | Buy | +31.3% | Assigned | 17.08.26on TipRanks Aug 16 22:30 | −5.3%next day +4.5% · 5 days +8.2% | ↗ |
| Jailendra Singh★★★★★★★★★★#12131 · hits 43% · avg −6.4% | Truist Financial | $7.00 → $6.00−14.3% | Hold | +31.3% | Assigned | 12.08.26on TipRanks 07:35 | +1.5%next day +11.1% · 5 days +10.3% | ↗ |
| Daniel Grosslight★★★★★★★★★★#4007 · hits 47% · avg +3.6% | Citi | $6.75 → $6.00−11.1% | Buy | +31.3% | Upgrade | 11.08.26on TipRanks Aug 10 16:15 | +4.6%next day +1.5% · 5 days +12.1% | ↗ |
| Richard Close★★★★★★★★★★#1081 · hits 49% · avg +10.0% | Canaccord Genuity | $7.00 → $6.00−14.3% | Buy | +31.3% | Reiterated | 10.08.26on TipRanks 07:20 | −0.5%next day +4.6% · 5 days +12.3% | ↗ |
| Matthew Gillmor CFA★★★★★★★★★★#6184 · hits 53% · avg +2.0% | KeyBanc | — | Hold | — | Reiterated | 10.08.26on TipRanks 03:55 | −0.5%next day +4.6% · 5 days +12.3% | ↗ |
| Michael Wiederhorn★★★★★★★★★★#535 · hits 59% · avg +11.3% | Oppenheimer | $6.00 | Buy | +31.3% | Assigned | 07.08.26on TipRanks 08:20 | +9.4%next day −0.5% · 5 days +18.1% | ↗ |
| Sean Dodge★★★★★★★★★★#11980 · hits 43% · avg −4.3% | BMO Capital | $6.00 | Buy | +31.3% | Reiterated | 06.08.26on TipRanks Aug 7 08:10 | +16.7%next day +9.4% · 5 days +28.6% | ↗ |
| Matthew Shea★★★★★★★★★★#6280 · hits 52% · avg +3.4% | Needham | $5.00 | Buy | +9.4% | Reiterated | 06.08.26on TipRanks 17:36 | +9.4%next day −0.5% · 5 days +18.1% | ↗ |
| Ryan Daniels★★★★★★★★★★#2878 · hits 48% · avg +5.8% | William Blair | — | Buy | — | Reiterated | 06.08.26on TipRanks 13:35 | +16.7%next day +9.4% · 5 days +28.6% | ↗ |
| David Larsen★★★★★★★★★★#12072 · hits 35% · avg −4.7% | BTIG | $8.00 | Buy | +75.1% | Assigned | 16.07.26on TipRanks 06:50 | −2.9%next day +3.5% · 5 days −16.5% | ↗ |
| Kevin Caliendo★★★★★★★★★★#2646 · hits 56% · avg +5.6% | UBS | $5.00 | Buy | +9.4% | Reiterated | 08.05.26on TipRanks 06:40 | −2.9%next day −5.5% · 5 days −5.5% | ↗ |
| Jeffrey Garro★★★★★★★★★★#12266 · hits 30% · avg −24.4% | Stephens | $7.00 | Buy | +53.2% | Reiterated | 25.02.26on TipRanks Feb 26 09:45 | +21.8%next day +6.3% · 5 days +14.2% | ↗ |
| Constantine Davides★★★★★★★★★★#12158 · hits 36% · avg −12.7% | Citizens JMP | $11.00 → $10.00−9.1% | Buy | +118.8% | Reiterated | 06.01.26on TipRanks 05:45 | +1.2%next day +3.6% · 5 days −0.5% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Evolent Health
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $5.80 at a price of $3.49 (+66.2%); now: $5.56 at $4.57 (+21.6%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Buy | 7 | 5 | 7 | 5 | 5 | 3 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.06 (from $0.01 to $0.10). Last quarter: $0.02.
Sales
Next quarter’s sales estimate — $727M (from $687M to $755M). Last quarter: $653M.
Best top-analyst consensus in the sector · Healthcare
About Evolent Health
- CEO: Seth Barrie Blackley
- Employees: 4,200
- 1812 N. Moore Street, Arlington, VA, 22209, US
- www.evolent.com
Evolent Health, Inc., a prominent healthcare firm, operates through its subsidiary, Evolent Health LLC, to furnish clinical and administrative solutions to both healthcare payers and providers across the United States. Its operations are divided into two principal segments: Evolent Health Services and Clinical Solutions. The Evolent Health Services division delivers an integrated platform encompassing both administrative and clinical functions, specifically designed for health plan management and the oversight of population health. This includes essential financial and administrative support, such as managing health plan operations, risk assessment, robust analytics and reporting, and strategic leadership. A cornerstone of this segment is "Identifi," its proprietary technology, which intelligently aggregates and analyzes data, streamlines care workflows, and actively engages patients, all with the aim of achieving patient-centered and cost-effective population health outcomes. Conversely, the Clinical Solutions segment specializes in offering sophisticated care management services for various stakeholders involved in specialty care delivery. These services are crucial for organizations transitioning from traditional fee-for-service models to value-based care, accommodating their unique stage of development and prevailing market dynamics, particularly in the fields of oncology and cardiology. The overarching objective of this segment is a holistic improvement in the total cost of care. Founded in 2011, Evolent Health, Inc. maintains its corporate headquarters in Arlington, Virginia.
Data from the stock’s TipRanks forecast page, read 10 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗